Skip to main content
. 2015 Jan 12;212(1):5–14. doi: 10.1084/jem.20141318

Figure 3.

Figure 3.

Anti-HMGB1 mAb administration ameliorates APAP-induced liver injury in mice. (A) Mice received an APAP injection (i.p.) followed by treatment with an anti-HMGB1 antibody or control IgG injection (i.p.; see Materials and methods). Animal survival (percent survival) was assessed. n = 20 mice/group. *, P < 0.05 versus IgG group. (B) Serum levels of liver enzyme (ALT) and cytokines (TNF and IL-6) at 24 h after APAP were measured in mice receiving treatment of anti-HMGB1 antibody or control IgG (see Materials and methods). *, P < 0.05 versus IgG group. n = 10 mice/group. (A and B) Data are presented as means ± SEM.